Intracerebral development of transplanted glioblastoma C6 cells in rats after preliminary exposure to neuropeptides and an MAPK inhibitor

Neuroscience and Behavioral Physiology

Volumn 38, Issue 9, 2008, Pages 913-916

  Tencheva, Ts S ^a   Panov, I R ^b  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Glioma cells; Proliferation; Transplantation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENDOTHELIN 1; MAX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MYC PROTEIN; NEUROPEPTIDE; THYMIDINE; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; GLIOBLASTOMA; GLIOMA CELL; IN VITRO STUDY; NONHUMAN; RAT; TRANSCRIPTION REGULATION;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; E2F1 TRANSCRIPTION FACTOR; ENDOTHELIN-1; FLAVONOIDS; GLIOBLASTOMA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, WISTAR;

EID: 56249084900     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-008-9072-8     Document Type: Article

References (12)

1. N. C. Andrews and D. V. Fuller, "A rapid micropreparation technique for extraction of DNA-binding proteins from limiting number of mammalian cells," Nucl. Acids Res., 19, 24 (1991).
2. 2+ mobilization in rat C6 glioma cells," J. Neurosci., 14, 5858-5864 (1994).
3. K. Blumer and G. Johnson, "Diversity in function and regulation of MAP kinase pathways," Trends Biochem. Sci., 19, 236-240 (1994).
4. E. Cane and L. Mahadevan, "Parallel signaling processing among mammalian MAPKS," Trends Biochem. Sci., 20, 117-122 (1995).
5. L. Chang and M. Karin, "Mammalian MAP kinase signaling cascades," Nature, 410, 37-40 (2001).
6. P.-O. Courand, O. Durieu-Trautmann, D. L. Nguyen, et al., "Functional endothelin-1 receptors in rat astrocytoma C6," Eur. J. Pharmacol., 206, 191-198 (1991).
7. N. Dyson, "The regulation of E2F by pRB-family proteins," Genes Dev., 12, 2245-2262 (1998).
8. J. R. Nevins, "Toward an understanding of the functional complexity of the E2F and retinoblastoma families," Cell Growth Differ., 9, 585-593 (1998).
9. J. R. Nevins, "The Rb/E2F pathway and cancer," Hum. Mol. Genet., 10, 699-703 (2001).
10. A. Saito, R. Shiba, S. Kimura, et al., "Vasoconstrictor responses of large cerebral arteries of cats to endothelin, an endothelium-derived vasoactive peptide," Eur. J. Pharmacol., 162, 353-358 (1989).
11. P. J. S. Stork and J. M. Schmitt, "Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation," Trends Cell Biol., 12, 258-266 (2002).
12. Z. S. Tencheva, M. M. Belcheva, A. A. Velichkova, et al., "Opioid regulation of AP-1 DNA binding activity in NG 108-15 cells under conditions of opioid receptor adaptation," Mol. Brain Res., 48, 156-158 (1997).